55
Cambrian BioPharma Inc raises $123.8M under Reg D
Company raise · Raising · Offering $129.8M · Sold $123.8M · NEW YORK, NY · filed 2026-07-15
Business combination
27
Cambrian BioPharma Inc files Form D
Company raise update · Raising · NEW YORK, NY · Form D/A filed 2025-01-13
$10M+ raise
Why now — by persona
Relevant to: B2B software & services sales. Lead card pending.
People on the filing
| Christian G. Angermayer | Director |
| Maryanna G. Saenko | Director |
| Paul G. Farr | Director |
| James G. Peyer | Executive Officer, Director |
| Brenton G. Saunders | Director |
Signed by James G. Peyer, Chief Executive Officer.
Filing contact
The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.